Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
The Medicines Company
The Medicines Company
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Angiox
Bivalirudin
2004-09-20
2028-2039
Acute coronary syndrome
,
Unstable angina
Ionsys
Fentanyl
2006-05-22
2024-2033
Neoplasms
,
Pain
,
Postoperative pain
,
Psychotic disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fentanyl
cancer pain
,
neoplasms
,
pain
,
breakthrough pain
Bivalirudin
myocardial infarction
,
infarction
,
coronary artery bypass
,
acute coronary syndrome
,
cardiovascular diseases
,
unstable angina
,
acute disease
,
inferior wall myocardial infarction
,
hemorrhage
,
endovascular procedures
,
aortic valve stenosis
,
transcatheter aortic valve replacement
,
cardiac surgical procedures
,
heart diseases
,
thrombosis
,
syndrome
,
thrombocytopenia
,
coronary artery disease
,
coronary disease
,
myocardial ischemia
,
stable angina
P2y purinoceptor 12
acute coronary syndrome
,
percutaneous coronary intervention
,
atherosclerosis
,
myocardial infarction
,
st elevation myocardial infarction
,
non-st elevated myocardial infarction
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use